Biotech Analyst Gershell discusses considerations ahead of the FDA’s Cardiovascular and Renal Drugs Advisory Committee Virtual Meeting for Alnylam Pharmaceuticals’ Onpattro label expansions on an Analyst/Industry conference call to be held on August 7 at 12 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALNY:
- Alnylam price target raised to $266 from $265 at Citi
- Alnylam reports Q2 EPS ($1.62), consensus ($1.72)
- Agios Pharmaceuticals announces license agreement with Alnylam
- Oppenheimer biotechnology analyst to hold an analyst/industry conference call
- ALNY Upcoming Earnings Report: What to Expect?
Questions or Comments about the article? Write to editor@tipranks.com